Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Kenakin

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Receptors & Channels|November 8, 2001
Quantitation in receptor pharmacologyT P Kenakin
British Journal of Pharmacology|August 19, 2007
Pharmacological onomastics: what's in a name?T P Kenakin
Molecular Pharmacology|April 1, 1992
Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressionsT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptorsT P Kenakin
The Journal of Pharmacy and Pharmacology|December 1, 1980
One the importance of agonist concentration-gradients within isolated tissues. Increased maximal responses of rat vasa deferentia to (--)-noradrenaline after blockade of neuronal uptakeT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
The potentiation of cardiac responses to adenosine by benzodiazepinesT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1981
The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processesT P Kenakin, D Beek
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenoniumT P Kenakin, D Beek
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1980
Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationshipsT P Kenakin, D Beek
Journal of Autonomic Pharmacology|September 1, 1984
The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissueT P Kenakin, D Beek
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Receptors & Channels|November 8, 2001
Quantitation in receptor pharmacologyT P Kenakin
British Journal of Pharmacology|August 19, 2007
Pharmacological onomastics: what's in a name?T P Kenakin
Molecular Pharmacology|April 1, 1992
Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressionsT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1982
Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptorsT P Kenakin
The Journal of Pharmacy and Pharmacology|December 1, 1980
One the importance of agonist concentration-gradients within isolated tissues. Increased maximal responses of rat vasa deferentia to (--)-noradrenaline after blockade of neuronal uptakeT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
The potentiation of cardiac responses to adenosine by benzodiazepinesT P Kenakin
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1981
The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processesT P Kenakin, D Beek
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1985
Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenoniumT P Kenakin, D Beek
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1980
Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationshipsT P Kenakin, D Beek
Journal of Autonomic Pharmacology|September 1, 1984
The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissueT P Kenakin, D Beek
Pageof 6